Who invested in Medilink Therapeutics?
Medilink Therapeutics's investors include Qiming Venture Partners, Legend Capital and Highlight Capital.
Who invested in Medilink Therapeutics
Funding summaryUpdated 26 Oct 2026
$70Mraised across 1 round since 2022, from 1 source
- Latest round
- Series B, $70MMar 2022
- Investors
- 3
The rounds
- Mar 2022
Founders and team
From Medilink Therapeutics's own website: 2 founders, 2 on the team.
Jiaqiang CaiCo-founder & CSO & Co-CEO
Tony XueChairman, Founder & CEO
- Jason LiCFO
- Weichang ZhouCTO
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Medilink Therapeutics
How much has Medilink Therapeutics raised?
Medilink Therapeutics has raised $70M across 1 round since 2022.
When did Medilink Therapeutics last raise?
Medilink Therapeutics's most recent round was a Series B of $70M in Mar 2022.
What was Medilink Therapeutics's biggest round?
Its most recent round, $70M in Mar 2022, is also its largest on record.
Who backed Medilink Therapeutics first?
Medilink Therapeutics's first round on record, in Mar 2022, was backed by Qiming Venture Partners, Legend Capital and Highlight Capital.
What stage is Medilink Therapeutics at?
Medilink Therapeutics's latest named round is a Series B, in Mar 2022.
Companies like Medilink Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.